GFM
NBP

GF Fund Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

GF Fund Management’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.71K Buy
2,321
+279
+14% +$934 ﹤0.01% 600
2025
Q4 		$8.13K Buy
+2,042
New +$9.04K ﹤0.01% 596

Other funds holding NBP

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
ACM
AIHC Capital Management Central $120M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GF Fund Management's NBP Position: Q1 2026 in Review

GF Fund Management increased its NovaBridge Biosciences American Depositary Shares (NBP) stake by 14% in Q1 2026, buying an estimated $934 and bringing the position to 2,321 shares worth $5.71K. The position accounts for ﹤0.01% of the portfolio, ranked #600.

GF Fund Management first reported a position in NBP in Q4 2025 and has held it in 2 quarters since. The position peaked at $8.13K in Q4 2025. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

  • GF Fund Management held 2,321 shares of NovaBridge Biosciences American Depositary Shares worth $5.71K as of Q1 2026.
  • GF Fund Management bought 279 NovaBridge Biosciences American Depositary Shares shares in Q1 2026, an estimated $934.
  • NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of GF Fund Management's portfolio in Q1 2026, its #600 holding.
  • GF Fund Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2025 and has held it in 2 quarters since.
  • GF Fund Management's NovaBridge Biosciences American Depositary Shares position peaked at $8.13K in Q4 2025.
  • 48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.